These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3059 related articles for article (PubMed ID: 6766171)

  • 1. Antitumor effects of L-glutamic acid dihydroxyanilides against experimental melanoma.
    Wick MM; Rosowsky A; Ratliff J
    J Invest Dermatol; 1980 Feb; 74(2):112-4. PubMed ID: 6766171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analogues of L-glutamic Acid gamma-(4-hydroxyanilide) and gamma-(3,4-dihydroxyanilde) as potential agents against melanoma.
    Rsoswsky A; Wick MM; Kim SH
    J Med Chem; 1979 Sep; 22(9):1034-7. PubMed ID: 490547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma.
    Wick MM
    Cancer Res; 1980 May; 40(5):1414-8. PubMed ID: 6768447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-Dihydroxybenzylamine: an improved dopamine analog cytotoxic for melanoma cells in part through oxidation products inhibitory to dna polymerase.
    FitzGerald GB; Wick MM
    J Invest Dermatol; 1983 Feb; 80(2):119-23. PubMed ID: 6401786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents with potential specificity against melanotic melanoma.
    Lin AJ; Kelley JA; Breitman TR; Driscoll JS
    J Med Chem; 1982 May; 25(5):501-5. PubMed ID: 7086835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Utilization of melanin precursors for experimental chemotherapy of malignant melanoma].
    Jimbow K; Miura S; Ito Y; Kasuga T; Ito S
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2125-32. PubMed ID: 6435538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine: a novel antitumor agent active against B-16 melanoma in vivo.
    Wick MM
    J Invest Dermatol; 1978 Aug; 71(2):163-4. PubMed ID: 681787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa and dopamine analogs: dihydroxy and trihydroxybenzylamines as novel quinol antitumor agents in experimental leukemia in vivo.
    Wick MM
    Cancer Treat Rep; 1981; 65(9-10):861-7. PubMed ID: 7273019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
    Jimbow K
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanogenesis-targeted anti-melanoma pro-drug development: effect of side-chain variations on the cytotoxicity of tyrosinase-generated ortho-quinones in a model screening system.
    Riley PA; Cooksey CJ; Johnson CI; Land EJ; Latter AM; Ramsden CA
    Eur J Cancer; 1997 Jan; 33(1):135-43. PubMed ID: 9071913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and actions of a melanotropin conjugate, Ac-[Nle4, Glu(gamma-4'-hydroxyanilide)5, D-Phe7]alpha-MSH4-10-NH2, on melanocytes and melanoma cells in vitro.
    al-Obeidi F; Mulcahy M; Pitt VS; Begay V; Hadley ME; Hruby VJ
    J Pharm Sci; 1990 Jun; 79(6):500-4. PubMed ID: 2168479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-Dihydroxybenzylamine: a dopamine analog with enhanced antitumor activity against B16 melanoma.
    Wick MM
    J Natl Cancer Inst; 1979 Dec; 63(6):1465-7. PubMed ID: 292814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular activation of gamma-L-glutaminyl-4-hydroxybenzene by tyrosinase, a mechanism for selective cytotoxicity against melanocarcinoma.
    Vogel FS; Kemper LA; Boekelheide K; Graham DG; Jeffs PW
    Cancer Res; 1979 May; 39(5):1490-3. PubMed ID: 106959
    [No Abstract]   [Full Text] [Related]  

  • 14. Specificity of growth inhibition of melanoma by 4-hydroxyanisole.
    Kulkarni GA; Nathanson L
    Pigment Cell Res; 1989; 2(1):40-3. PubMed ID: 2497444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells.
    Morrison ME; Yagi MJ; Cohen G
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2960-4. PubMed ID: 3921968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gamma-L-Glutaminyl-4-hydroxybenzene, an inducer of cryptobiosis in Agaricus bisporus and a source of specific metabolic inhibitors for melanogenic cells.
    Vogel FS; Kemper LA; Jeffs PW; Cass MW; Graham DG
    Cancer Res; 1977 Apr; 37(4):1133-6. PubMed ID: 403000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase as a target for melanoma destruction?
    Smit NP; Latter AJ; Naish-Byfield S; Westerhof W; Pavel S; Riley PA
    Biochem Pharmacol; 1994 Aug; 48(4):743-52. PubMed ID: 8080447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo anti-tumor activity of L-glutamic acid gamma-monohydroxamate against L1210 leukemia and B16 melanoma.
    Vila J; Thomasset N; Navarro C; Doré JF
    Int J Cancer; 1990 Apr; 45(4):737-43. PubMed ID: 2323850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
    Yamazaki Y; Kawano Y; Yamanaka A; Maruyama S
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4178-82. PubMed ID: 19524439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor properties of selected 1,2,4-triazine derivatives.
    Mordarski M; Wieczorek J; Fiszer L; Nantka-Namirski P; Rykowski A
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):717-25. PubMed ID: 7212979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 153.